Basic Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 105933
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105933
Table 1 Sequence of primers
Name
Forward/sense (from 5’ to 3’)
Reverse/antisense (from 5’ to 3’)
circRNA_101996 GAGTGGGAGTGTTGGAAGAAGTTACTAAAGGCAAACGGTGAA
miR-577GCGGCGGTAGATAAAATATTGGATCCAGTGCAGGGTCCGAGG
HMGN5GGTTGTCTGCTATGCTTGTGACTGCTTCTTGCTTGGTTTC
GAPDHGGAGAGTGTTTCCTCGTCCCACTGTGCCGTTGAATTTGCC
U6GCGCGTCGTGAAGCGTTCGTGCAGGGTCCGAGGT
Table 2 The correlation between hsa_circRNA_101996/miR-577/HMGN5 level in gastric cancer tissue and the clinical characteristics of patients, n
Clinical characteristicshsa_circRNA_101996
miR-577
HMGN5
Low expression group (≤ median)
High expression group (> median)
P value
Low expression group (≤ median)
High expression group (> median)
P value
Low expression group (≤ median)
High expression group (> median)
P value
Gender0.4430.8900.162
    Male81099711
    Female13101211149
Age0.8900.2620.443
    > 50121110131310
    ≤ 5099117810
Body mass index (kg/m2)0.8370.3930.275
    > 24131312141511
    ≤ 24879669
Tumor size (cm)< 0.0010.0430.003
    > 3516147615
    ≤ 3164713155
TNM stage0.6540.0860.412
    1-289611107
    3-413111591113